Part 1. Restricting access under Medicare Part D The Trump administration is out with its plan to lower the cost of prescription drug for America’s patients. The plan rightly rejects the flawed schemes we hear regularly from pundits and the media – importation and direct government price negotiation in Medicare – that together would weaken …
Read Article: On the President’s Drug Cost Plan, Three Important Concerns